Chemocentryx Stock Buy Hold or Sell Recommendation

CCXI -  USA Stock  

USD 15.32  0.21  1.39%

Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Chemocentryx is 'Strong Sell'. Macroaxis provides Chemocentryx buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding CCXI positions. The advice algorithm takes into account all of Chemocentryx's available fundamental, technical, and predictive indicators you will find on this site.

Search Advice 

 
Refresh
The advice is provided from Chemocentryx's buy-and-hold perspective. Continue to Chemocentryx Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. We conduct extensive research on individual companies such as Chemocentryx and provide practical buy, sell, or hold advice based on selected investing horizon and risk tolerance towards Chemocentryx.

Execute Chemocentryx Buy or Sell Advice

The Chemocentryx recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Chemocentryx. Macroaxis does not own or have any residual interests in Chemocentryx or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Chemocentryx's advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell ChemocentryxBuy Chemocentryx
Strong Sell

Volatility

Slightly riskyDetails

Hype Condition

Under hypedDetails

Current Valuation

UndervaluedDetails

Odds of Distress

Below AverageDetails

Economic Sensitivity

Very regressive towards the marketDetails

Analyst Consensus

HoldDetails

Financial Strenth (F Score)

FrailDetails

Financial Leverage

InapplicableDetails

Reporting Quality (M-Score)

Possible ManipulatorDetails
For the selected time horizon Chemocentryx has a Mean Deviation of 4.73, Standard Deviation of 10.2 and Variance of 104.08
Our trade advice tool can cross-verify current analyst consensus on Chemocentryx and to analyze the company potential to grow in the current economic cycle. To make sure Chemocentryx is not overpriced, please confirm all Chemocentryx fundamentals, including its cash and equivalents, beta, and the relationship between the price to sales and book value per share . Given that Chemocentryx has a number of shares shorted of 3.14 M, we suggest you to validate Chemocentryx market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your prevailing risk tolerance and investing horizon.

Chemocentryx Trading Alerts and Improvement Suggestions

Chemocentryx generates negative expected return over the last 90 days
Chemocentryx has high historical volatility and very poor performance
The company reported the previous year's revenue of 69.24 M. Net Loss for the year was (63.38 M) with loss before overhead, payroll, taxes, and interest of (12.99 M).
Chemocentryx currently holds about 376.28 M in cash with (75.26 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.39.
Chemocentryx has a frail financial position based on the latest SEC disclosures
Roughly 72.0% of the company shares are held by institutions such as insurance companies
Latest headline from www.equities.com: ChemoCentryx falls 3.48 percent in Light Trading on July 29 - Equities.com

Chemocentryx current analysts advice

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Chemocentryx analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Chemocentryx analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target Mean Price36.57
Target Median Price28.00
Target High Price79.00
Recommendation Mean2.50
Number Of Analyst Opinions7
Target Low Price17.00
Average Consensus Hold
The consensus estimates and target price estimation comprises individual analyst assessments, and may or may not mutch the Macroaxis buy or sell advice. It is determined by taking an average of all analyst recommendations and classifying them as Strong Buy, Buy, Hold, or Sell.

Chemocentryx Returns Distribution Density

The distribution of Chemocentryx's historical returns is an attempt to chart the future uncertainty of Chemocentryx's future price movements. The chart of the probability distribution of Chemocentryx stock daily returns describes the distribution of returns around its average expected value. We use Chemocentryx price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Chemocentryx returns is essential to provide solid investment advice for Chemocentryx stock.
Mean Return-0.94Value At Risk-6.06
Potential Upside6.88Standard Deviation10.20
 Return Density 
      Distribution 
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Chemocentryx historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Chemocentryx Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Chemocentryx is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Chemocentryx backward and forwards among themselves. Chemocentryx's institutional investor refers to the entity that pools money to purchase Chemocentryx's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Assenagon Asset Management SaCommon Shares104.2 K1.4 M
Cutler Group LpPut Options108.9 K960 K
Alliancebernstein LpCommon Shares70.8 K948 K
Strs OhioCommon Shares49.9 K668 K
New York State Common Retirement FundCommon Shares45.1 K604 K
Belvedere Trading LlcCommon Shares34.1 K550 K
Cutler Group LpCommon Shares38.6 K516 K
Chicago Partners Investment Group LlcCommon Shares24.4 K355 K
Cutler Group LpCall Options58.2 K129 K
Note, although Chemocentryx's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Chemocentryx Cash Flow Accounts

201620172018201920202021 (projected)
Capital Expenditure(304 K)(723 K)(838 K)(790 K)(15.41 M)(15.81 M)
Depreciation Amortization and Accretion348 K418 K512 K1.64 M2.77 M2.99 M
Net Cash Flow or Change in Cash and Cash Equivalents(799 K)28 M(11.93 M)12.17 M(6.88 M)(7.06 M)
Issuance Purchase of Equity Shares8.82 M3.27 M10.47 M96.13 M355.97 M384.08 M
Net Cash Flow from Financing8.82 M7.52 M24.7 M94.82 M356.62 M384.78 M
Net Cash Flow from Investing(48.76 M)15.6 M(53.07 M)(12.53 M)(282.36 M)(289.79 M)
Net Cash Flow Investment Acquisitions and Disposals(48.46 M)16.32 M(52.23 M)(11.74 M)(266.95 M)(273.98 M)
Net Cash Flow from Operations39.15 M4.88 M16.44 M(70.12 M)(81.14 M)(83.28 M)
Share Based Compensation8.54 M8.75 M10.83 M11.64 M22.91 M24.72 M

Chemocentryx Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Chemocentryx or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Chemocentryx stock's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Chemocentryx stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α
Alpha over DOW
-0.92
β
Beta against DOW-1.46
σ
Overall volatility
8.75
Ir
Information ratio -0.09

Chemocentryx Volatility Alert

Chemocentryx is displaying above-average volatility over the selected time horizon. Investors should scrutinize Chemocentryx independently to ensure intended market timing strategies are aligned with expectations about Chemocentryx volatility. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Chemocentryx's stock risk against market volatility during both bullying and bearish trends. The higher level of volatility that comes with bear markets can directly impact Chemocentryx's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall.

Chemocentryx Fundamentals Vs Peers

Comparing Chemocentryx's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Chemocentryx's direct or indirect competition across all of the common fundamentals between Chemocentryx and the related equities. This way, we can detect undervalued stocks with similar characteristics as Chemocentryx or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Chemocentryx's fundamental indicators could also be used in its relative valuation, which is a method of valuing Chemocentryx by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare Chemocentryx to competition
FundamentalsChemocentryxPeer Average
Return On Equity(30.10) %(0.31) %
Return On Asset(11.20) %(0.14) %
Profit Margin(91.54) %(1.27) %
Operating Margin(90.10) %(5.51) %
Current Valuation592.82 M16.62 B
Shares Outstanding69.75 M571.82 M
Shares Owned by Insiders23.74 %10.09 %
Shares Owned by Institutions72.45 %39.21 %
Number of Shares Shorted3.14 M4.71 M
Price to Earning40.53 X28.72 X
Price to Book2.86 X9.51 X
Price to Sales14.89 X11.42 X
Revenue69.24 M9.43 B
Gross Profit(12.99 M)27.38 B
EBITDA(61.61 M)3.9 B
Net Income(63.38 M)570.98 M
Cash and Equivalents376.28 M2.7 B
Cash per Share5.39 X5.01 X
Total Debt70.03 M5.32 B
Debt to Equity0.19 %48.70 %
Current Ratio7.14 X2.16 X
Book Value Per Share5.18 X1.93 K
Cash Flow from Operations(75.26 M)971.22 M
Short Ratio0.53 X4.00 X
Earnings Per Share(0.94) X3.12 X
Number of Employees13318.84 K
Beta1.44-0.15
Market Capitalization1.03 B19.03 B
Total Asset78.16 M29.47 B
Retained Earnings(441.3 M)9.33 B
Working Capital66.54 M1.48 B
Current Asset72.03 M9.34 B
Current Liabilities5.49 M7.9 B
   Exercise or conversion by Rita Jain of 4660 shares of Chemocentryx subject to Rule 16b-3 [view details]

Chemocentryx Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Chemocentryx . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
Accumulation Distribution52036.5
Daily Balance Of Power0.2958
Rate Of Daily Change1.01
Day Median Price15.37
Day Typical Price15.35
Market Facilitation Index0.0
Price Action Indicator0.06

About Chemocentryx Buy or Sell Advice

When is the right time to buy or sell Chemocentryx? Buying financial instruments such as Chemocentryx Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the stock market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Although Chemocentryx investors may find it confusing at the beginning, most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
 2018 2019 2020 2021 (projected)
Accounts Payable966 K1.53 M12.88 M13.89 M
Receivables2.06 M176 K137 K140.6 K

Use Investing Ideas to Build Portfolios

In addition to having Chemocentryx in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Alternative Energy Thematic Idea Now

Alternative Energy
Alternative Energy Theme
Large and mid-size companies, ETFs and funds that are either investing or directly involved in providing energy derived from sources not connected to fossil fuels, do not consume natural resources, and do not harm the environment. This includes wind power, nuclear and solar energy, biofuel, ethanol, hydrogen and others alternative sources of energy. Alternative Energy theme has 34 constituents.
View All  Next Launch Alternative Energy
Continue to Chemocentryx Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note that the Chemocentryx information on this page should be used as a complementary analysis to other Chemocentryx's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.

Complementary Tools for Chemocentryx Stock analysis

When running Chemocentryx price analysis, check to measure Chemocentryx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chemocentryx is operating at the current time. Most of Chemocentryx's value examination focuses on studying past and present price action to predict the probability of Chemocentryx's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Chemocentryx's price. Additionally, you may evaluate how the addition of Chemocentryx to your portfolios can decrease your overall portfolio volatility.
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Go
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Go
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go
Transaction History
View history of all your transactions and understand their impact on performance
Go
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Go
The market value of Chemocentryx is measured differently than its book value, which is the value of Chemocentryx that is recorded on the company's balance sheet. Investors also form their own opinion of Chemocentryx's value that differs from its market value or its book value, called intrinsic value, which is Chemocentryx's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chemocentryx's market value can be influenced by many factors that don't directly affect Chemocentryx underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chemocentryx's value and its price as these two are different measures arrived at by different means. Investors typically determine Chemocentryx value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chemocentryx's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.